THYMOGLOBULIN PLUS BASILIXIMAB VERSUS BASILIXIMAB INDUCTION IN DECEASED DONOR KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS AND MMF: 1-YEAR RESULTS OF A PROSPECTIVE CLINICAL TRIAL

被引：0
|
作者：
Favi, Evaldo
Spagnoletti, Gionata
Silvestrini, Nicola
Salerno, Maria P.
Pedroso, Jose A.
Romagnoli, Jacopo
Citterio, Franco
机构：
来源：
TRANSPLANT INTERNATIONAL | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [1] Thymoglobulin Plus Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: 1-Year Results of a Prospective Clinical Trial.
    Favi, E.
    Spagnoletti, G.
    Silvestrini, N.
    Salerno, M.
    Pedroso, J.
    Romagnoli, J.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 426 - 426
  • [2] Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial
    Favi, E.
    Silvestrini, N.
    Spagnoletti, G.
    Castagneto, M.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 147 - 147
  • [3] Induction with Thymoglobulin Plus Basiliximab Is Safe and Effective in Expanded Criteria Donor Kidney Transplant Recipients: 1-Year Results of a Prospective Clinical Trial.
    Favi, E.
    Silvestrini, N.
    Romagnoli, J.
    Salerno, M. P.
    Pedroso, J. A.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 318 - 319
  • [4] Thymoglobulin Versus Basiliximab Induction Therapy for Kidney Transplant From Deceased Donor With Acute Kidney Injury
    Jung, C.
    Jun, H.
    Kim, M.
    Park, K.
    Kim, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 583 - 583
  • [5] THYMOGLOBULIN VERSUS BASILIXIMAB INDUCTION THERAPY FOR KIDNEY TRANSPLANT FROM DECEASED DONOR WITH ACUTE KIDNEY INJURY
    Park, Kwantae
    Otgonbayar, Adiyakhuu
    TRANSPLANT INTERNATIONAL, 2017, 30 : 472 - 472
  • [6] Thymoglobulin Versus Basiliximab Induction Therapy for Kidney Transplant From Deceased Donor With Acute Kidney Injury.
    Jung, C.
    Jun, H.
    Kim, M.
    Park, K.
    Kim, S.
    TRANSPLANTATION, 2014, 98 : 583 - 583
  • [7] Thymoglobulin Versus Basiliximab Induction in Sensitized Deceased Donor Kidney Transplant Recipients: Short-Term Follow-Up
    Muth, B.
    Fernandez, L.
    Richards, K.
    Hager, D.
    Mezrich, J.
    Odorico, J.
    D'Alessandro, T.
    Pirsch, J.
    Bellingham, J.
    Foley, D.
    Kaufman, D.
    Djamali, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 229 - 229
  • [8] Lower Acute Rejection with Basiliximab and Short Course, Low Dose Thymoglobulin vs Basiliximab as Induction Therapy in Deceased Donor Renal Transplant Recipients: 6-Month Results of a Prospective Clinical Trial
    Favi, Evaldo
    Silvestrini, Nicola
    Valente, Iacopo
    Salerno, Maria Paola
    Castagneto, Marco
    Citterio, Franco
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 321 - 321
  • [9] Induction therapy with basiliximab versus thymoglobulin in African-American kidney transplant recipients
    Haririan, A
    Morawski, K
    Sillix, DH
    El-Amm, JM
    Garnick, J
    West, MS
    Granger, DK
    Migdal, SD
    Gruber, SA
    TRANSPLANTATION, 2005, 79 (06) : 716 - 721
  • [10] Outcomes of Basiliximab and Rapid Steroid Withdrawal versus Thymoglobulin Induction in Pediatric Kidney Transplant Recipients
    Steinman, Benjamin
    Kilduff, Stella
    Hayde, Nicole
    PEDIATRIC TRANSPLANTATION, 2023, 27
12345